- Home
- RDZN vs SERA Comparison
RDZN vs SERA Comparison
Compare RDZN & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDZN
- SERA
- Stock Information
- Founded
- RDZN 2015
- SERA 2008
- Country
- RDZN United States
- SERA United States
- Employees
- RDZN N/A
- SERA 64
- Industry
- RDZN Blank Checks
- SERA Precision Instruments
- Sector
- RDZN Finance
- SERA Health Care
- Exchange
- RDZN Nasdaq
- SERA Nasdaq
- Market Cap
- RDZN 79.4M
- SERA 70.4M
- IPO Year
- RDZN N/A
- SERA 2021
- Fundamental
- Price
- RDZN $0.95
- SERA $2.63
- Analyst Decision
- RDZN Strong Buy
- SERA
- Analyst Count
- RDZN 2
- SERA 0
- Target Price
- RDZN $5.00
- SERA N/A
- AVG Volume (30 Days)
- RDZN 653.6K
- SERA 803.6K
- Earning Date
- RDZN 06-26-2025
- SERA 08-06-2025
- Dividend Yield
- RDZN N/A
- SERA N/A
- EPS Growth
- RDZN N/A
- SERA N/A
- EPS
- RDZN N/A
- SERA N/A
- Revenue
- RDZN $44,296,098.00
- SERA $115,000.00
- Revenue This Year
- RDZN $4.52
- SERA $390.13
- Revenue Next Year
- RDZN $53.72
- SERA $440.54
- P/E Ratio
- RDZN N/A
- SERA N/A
- Revenue Growth
- RDZN N/A
- SERA N/A
- 52 Week Low
- RDZN $0.68
- SERA $1.37
- 52 Week High
- RDZN $3.28
- SERA $9.13
- Technical
- Relative Strength Index (RSI)
- RDZN 46.16
- SERA 55.80
- Support Level
- RDZN $1.00
- SERA $1.82
- Resistance Level
- RDZN $1.22
- SERA $4.09
- Average True Range (ATR)
- RDZN 0.12
- SERA 0.37
- MACD
- RDZN -0.01
- SERA 0.17
- Stochastic Oscillator
- RDZN 18.94
- SERA 44.92
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.